NCT05396560Recruiting
Fecal Immunochemical Test for Post-polypectomy Surveillance to Reduce Unnecessary eNdoscopy
Fecal Immunochemical Test for Post-polypectomy Surveillance to Reduce Unnecessary eNdoscopy (FIT2RUN Study)
Source: ClinicalTrials.gov · Last updated 31 May 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is an observational study in a clinical setting to estimate the prevalence of advanced colorectal neoplasia (ACN) at colonoscopy in those with a history of low or high risk polyps or a family history of CRC/polyps and to verify the test performance characteristics of FIT in these populations. Using this information, a risk prediction model will be developed to help guide the choice between FIT and colonoscopy in the ongoing surveillance or screening of patients.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 3000 (estimated)
- First submitted
- 16 May 2022
- Start date
- 15 Apr 2022
- Primary completion date
- 15 Apr 2026
- Lead sponsor
- University of Calgary
- Diseases
- Colorectal cancer
- NCT number
- NCT05396560
What you commit to
- Study type: Observational
- Planned participants: 3000
- From 15 Apr 2022 to the primary completion date, 15 Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Colonoscopy within the previous 30 months
Other illness
- Known or suspected gene carrier for a familial cancer syndrome.
Other
- Known acromegaly, cystic fibrosis or high risk profession (firefighter)
- Referred for colonoscopy due to a positive fecal immunochemical test or CT colonography
- Does not meet medical criteria for colonoscopy at the CCSC.
- Unable to provide written informed consent or complete questionnaires due to language barrier or other reasons.
Who the study is looking for
- Men or women age ≤ 74 years of age.
- At least one risk factor for CRC that would generally lead to colonoscopy screening:
- Personal history of low risk polyps
- Personal history of high risk polyps
- Family history of CRC or polyps
Age in the registry: 18 years to 74 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Forzani & Macphail Colon Cancer Screening Centre, University of Calgary Coordinator of this site? Confirm its status | Calgary | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.